Vyant Bio Investor Relations Material
Latest events
Q3 2022
Vyant Bio
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Vyant Bio Inc
Access all reports
Vyant Bio, Inc. operates as a biotechnology drug discovery company. The company discovers, develops, and commercializes antimicrobial drugs to treat acute respiratory tract infections, including pneumonia and influenza.
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
VYNT
Country
🇺🇸 United States